YA II PN, Ltd. 13D and 13G filings for Kiromic BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 7:38 pm Sale | 2024-09-30 | 13G | Kiromic BioPharma, Inc. KRBP | YA II PN, Ltd. | 0 0.000% | -139,674 (Position Closed) | Filing |
| 2024-02-12 9:56 pm Purchase | 2023-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | YA II PN, Ltd. | 139,674 9.990% | 139,674 (New Position) | Filing |